Literature DB >> 32288915

Veterinary Vaccines and Their Importance to Animal Health and Public Health.

James A Roth1.   

Abstract

Veterinary vaccines have had, and continue to have, a major role in protecting animal health and public health, reducing animal suffering, enabling efficient production of food animals to feed the burgeoning human population, and greatly reducing the need for antibiotics to treat food and companion animals. Prominent examples include rabies vaccines and rinderpest vaccines. Rabies vaccines for domestic animals and wildlife have nearly eliminated human rabies in developed countries. Thanks to the Global Rinderpest Eradication Program which involves vaccination, trade restrictions, and surveillance, rinderpest may soon become only the second disease (after smallpox) to be globally eradicated. Successful examples of new technology animal vaccines that are licensed for use, include gene-deleted marker vaccines, virus-like-particle vaccines, recombinant modified live virus vaccines, chimeric vaccines, and DNA vaccines. Animal vaccines also use a wide variety of novel adjuvants that are not yet approved for use in human vaccines. Animal vaccines can be developed and licensed much more quickly than human vaccines. The West Nile virus was discovered in the United States in August 1999. By August 2001, an Equine vaccine for West Nile virus was conditionally licensed. For animal vaccines to effectively protect animal and public health they must be widely used, which means they must be affordable. The regulatory process must meet the need for assuring safety and efficacy without increasing the cost of licensing and production to the point where they are not affordable to the end user.
Copyright © 2011 Published by Elsevier B.V.

Entities:  

Keywords:  animal health; immunization; infectious diseases; public health; vaccine

Year:  2011        PMID: 32288915      PMCID: PMC7128871          DOI: 10.1016/j.provac.2011.10.009

Source DB:  PubMed          Journal:  Procedia Vaccinol


  15 in total

Review 1.  Veterinary vaccine nanotechnology: pulmonary and nasal delivery in livestock animals.

Authors:  Daniella Calderon-Nieva; Kalhari Bandara Goonewardene; Susantha Gomis; Marianna Foldvari
Journal:  Drug Deliv Transl Res       Date:  2017-08       Impact factor: 4.617

2.  Porcine circovirus type 2 and its associated diseases in southwestern Nigeria: Farmers' perception and level of awareness.

Authors:  Oluwawemimo Oluseun Adebowale; Olufemi Samuel Amoo; Kayode Olayinka Afolabi; Abimbola Adetokunbo Oloye
Journal:  J Adv Vet Anim Res       Date:  2022-06-26

3.  Livestock vaccination programme participation among smallholder farmers on the outskirts of National Parks and Tiger Reserves in the Indian states of Madhya Pradesh and Assam.

Authors:  Andy Hopker; Naveen Pandey; Rosie Bartholomew; Abigail Blanton; Sophie Hopker; Aniruddha Dhamorikar; Jadumoni Goswami; Rebecca Marsland; Prakash Metha; Neil Sargison
Journal:  PLoS One       Date:  2021-08-27       Impact factor: 3.240

4.  Short communication: a modified Vaccinia virus Ankara-based Porcine circovirus 2 vaccine elicits strong antibody response upon prime-boost homologous immunization in a preclinical model.

Authors:  Danielle Soares de Oliveira Daian E Silva; Edel Figueiredo Barbosa-Stancioli; Jordana Graziela Alves Coelho-Dos-Reis; Flávio Guimarães Da Fonseca
Journal:  Braz J Microbiol       Date:  2020-03-06       Impact factor: 2.476

5.  Hesitancy Toward a COVID-19 Vaccine.

Authors:  Linda Thunström; Madison Ashworth; David Finnoff; Stephen C Newbold
Journal:  Ecohealth       Date:  2021-06-04       Impact factor: 3.184

6.  Supplementing young cattle with a rumen-protected grape extract around vaccination increases humoral response and antioxidant defenses.

Authors:  Paul Engler; Clémence Desguerets; Mohamed El Amine Benarbia; Yassine Mallem
Journal:  Vet Anim Sci       Date:  2022-01-14

7.  Does social deprivation correlate with meningococcal MenACWY, Hib/MenC and 4CMenB/Meningococcal Group B vaccine uptake in Northern Ireland?

Authors:  Orlaith C Brennan; John E Moore; Beverley C Millar
Journal:  Ulster Med J       Date:  2022-02-11

8.  Non-animal replacement methods for veterinary vaccine potency testing: state of the science and future directions.

Authors:  Jodie Kulpa-Eddy; Geetha Srinivas; Marlies Halder; Richard Hill; Karen Brown; James Roth; Hans Draayer; Jeffrey Galvin; Ivo Claassen; Glen Gifford; Ralph Woodland; Vivian Doelling; Brett Jones; William S Stokes
Journal:  Procedia Vaccinol       Date:  2011-12-23

9.  2018 Survey of factors associated with antimicrobial drug use and stewardship practices in adult cows on conventional California dairies: immediate post-Senate Bill 27 impact.

Authors:  Pius S Ekong; Essam M Abdelfattah; Emmanuel Okello; Deniece R Williams; Terry W Lehenbauer; Betsy M Karle; Joan D Rowe; Sharif S Aly
Journal:  PeerJ       Date:  2021-07-13       Impact factor: 2.984

Review 10.  Using cross-species vaccination approaches to counter emerging infectious diseases.

Authors:  George M Warimwe; Michael J Francis; Thomas A Bowden; Samuel M Thumbi; Bryan Charleston
Journal:  Nat Rev Immunol       Date:  2021-06-17       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.